These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 16504004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines.
    Alao JP, Gamble SC, Stavropoulou AV, Pomeranz KM, Lam EW, Coombes RC, Vigushin DM.
    Mol Cancer; 2006 Feb 17; 5():7. PubMed ID: 16503970
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
    Alao JP, Lam EW, Ali S, Buluwela L, Bordogna W, Lockey P, Varshochi R, Stavropoulou AV, Coombes RC, Vigushin DM.
    Clin Cancer Res; 2004 Dec 01; 10(23):8094-104. PubMed ID: 15585645
    [Abstract] [Full Text] [Related]

  • 4. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells.
    Alao JP, Stavropoulou AV, Lam EW, Coombes RC.
    Mol Cancer; 2006 Oct 03; 5():40. PubMed ID: 17018141
    [Abstract] [Full Text] [Related]

  • 5. The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
    Eo HJ, Park GH, Jeong JB.
    Phytomedicine; 2016 Feb 15; 23(2):105-13. PubMed ID: 26926171
    [Abstract] [Full Text] [Related]

  • 6. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.
    Zhou Q, Melkoumian ZK, Lucktong A, Moniwa M, Davie JR, Strobl JS.
    J Biol Chem; 2000 Nov 10; 275(45):35256-63. PubMed ID: 10938272
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway.
    Yuan Y, Fan Y, Gao Z, Sun X, Zhang H, Wang Z, Cui Y, Song W, Wang Z, Zhang F, Niu R.
    Cancer Biol Med; 2020 Aug 15; 17(3):707-725. PubMed ID: 32944401
    [Abstract] [Full Text] [Related]

  • 11. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
    Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA.
    Oncogene; 2006 Oct 12; 25(47):6291-303. PubMed ID: 16732330
    [Abstract] [Full Text] [Related]

  • 12. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB, Lee KH, Sugita K, Yoshida M, Horinouchi S.
    Oncogene; 1999 Apr 15; 18(15):2461-70. PubMed ID: 10229197
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
    Qin C, Burghardt R, Smith R, Wormke M, Stewart J, Safe S.
    Cancer Res; 2003 Mar 01; 63(5):958-64. PubMed ID: 12615709
    [Abstract] [Full Text] [Related]

  • 14. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
    Yu XJ, Han QB, Wen ZS, Ma L, Gao J, Zhou GB.
    Cancer Lett; 2012 Sep 28; 322(2):185-94. PubMed ID: 22410463
    [Abstract] [Full Text] [Related]

  • 15. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
    Wei S, Yang HC, Chuang HC, Yang J, Kulp SK, Lu PJ, Lai MD, Chen CS.
    J Biol Chem; 2008 Sep 26; 283(39):26759-70. PubMed ID: 18650423
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
    Liu L, Zhang H, Shi L, Zhang W, Yuan J, Chen X, Liu J, Zhang Y, Wang Z.
    Oncol Rep; 2014 Oct 26; 32(4):1395-400. PubMed ID: 25109327
    [Abstract] [Full Text] [Related]

  • 17. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.
    Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F, Tetsu O.
    PLoS One; 2006 Dec 27; 1(1):e128. PubMed ID: 17205132
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.
    Hamelers IH, van Schaik RF, Sipkema J, Sussenbach JS, Steenbergh PH.
    J Biol Chem; 2002 Dec 06; 277(49):47645-52. PubMed ID: 12364325
    [Abstract] [Full Text] [Related]

  • 19. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export.
    Yoshida M, Horinouchi S.
    Ann N Y Acad Sci; 1999 Dec 06; 886():23-36. PubMed ID: 10667200
    [Abstract] [Full Text] [Related]

  • 20. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T.
    Exp Cell Res; 2005 Nov 01; 310(2):426-33. PubMed ID: 16153639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.